HPV Status Impacts Head and Neck Cancer Outcomes

Posted on Mar 31, 2013 in Research

Human papilloma virus (HPV) infection impacts response to treatment for head and neck cancer, Georgetown researchers find.

Previous studies have found that head and neck cancer patients have a better prognosis if they are positive for the HPV virus. In new research, HPV status also guided treatment choices.  Patients with HPV-positive head and neck cancer responded better to treatment with Cetuximab and radiation therapy than did those who did not have the virus. Read the full story here.